Argent Capital Management LLC Gilead Sciences, Inc. Transaction History

Argent Capital Management LLC

$3.53 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $356,385 - $404,149	-4,864 Reduced 2.1%	226,729 $18.4 Million
Q3 2023 Oct 24, 2023	SELL	$73.94 - $80.67 $1.68 Million - $1.84 Million	-22,762 Reduced 8.95%	231,593 $17.4 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $257,597 - $293,826	-3,389 Reduced 1.31%	254,355 $19.6 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $7.26 Million - $8.27 Million	93,863 Added 57.28%	257,744 $21.4 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $56,648 - $81,328	-909 Reduced 0.55%	163,881 $14.1 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $200,887 - $229,465	3,374 Added 2.09%	164,790 $10.2 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $376,796 - $424,385	-6,528 Reduced 3.89%	161,416 $9.98 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $6,776 - $8,491	117 Added 0.07%	167,944 $9.98 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $32,310 - $36,672	-498 Reduced 0.3%	167,827 $12.2 Million
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $22,608 - $24,392	334 Added 0.2%	168,325 $11.8 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $9,203 - $10,055	145 Added 0.09%	167,991 $11.6 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $249,480 - $284,656	4,158 Added 2.54%	167,846 $10.8 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $303,134 - $345,407	-5,351 Reduced 3.17%	163,688 $9.54 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $108,675 - $136,640	-1,750 Reduced 1.02%	169,039 $10.7 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $781,706 - $907,704	-10,806 Reduced 5.95%	170,789 $13.1 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $223,275 - $285,984	-3,565 Reduced 1.93%	181,595 $13.6 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $69,877 - $76,862	1,134 Added 0.62%	185,160 $12 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $140,209 - $154,767	-2,243 Reduced 1.2%	184,026 $11.7 Million
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $615,297 - $689,984	-9,945 Reduced 5.07%	186,269 $12.6 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $9.16 Million - $10.3 Million	146,530 Added 294.92%	196,214 $12.8 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $7.99 Million - $10.4 Million	-132,040 Reduced 72.66%	49,684 $3.11 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $1.08 Million - $1.2 Million	-15,180 Reduced 7.71%	181,724 $14 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $316,938 - $369,696	4,885 Added 2.54%	196,904 $13.9 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $246,199 - $300,144	-3,380 Reduced 1.73%	192,019 $14.5 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $34,863 - $40,924	-490 Reduced 0.25%	195,399 $16.4 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $14.1 Million - $16.7 Million	195,889	195,889 $15.9 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.

Account